intellectual disability, autosomal dominant 1

Rare Disease

MONDO:0007974

Also known as:

MBD5 autosomal dominant non-syndromic intellectual disabilityMRD1autosomal dominant intellectual disability 1

An autosomal dominant condition caused by mutation(s) in the MBD5 gene, encoding methyl-CpG-binding domain protein 5. It is characterized by severe developmental and cognitive delay, short stature, cr...

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Companies Active in intellectual disability, autosomal dominant 1

0 approved

Organizations with approved therapies for this disease

No approved therapies yet

Research is ongoing — 2 companies have orphan drug designations for this disease

Gilead Sciences, Inc.

Other

Designated

Theratechnologies Inc.

Other

Designated

View all companies active in intellectual disability, autosomal dominant 1

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases